Table 1

 Summary of the methodology and results of 21 stimulant growth studies in children

Design: longitudinal from onset of treatment with stimulant
Control: untreated children with ADHD or normal children
Treatment (mg/day)nΔ Height centileΔ Height z-scoreΔ Calculated adult heightHeight deficit (cm)
Safer and Allen, 19731Mph >2010p<0.05 (3 years)1.0 cm/year*
Mph ⩽2010NS
Dex 12.529p<0.005 (2.9 years)1.5 cm/year*
Kalachnik et al, 19823Mph 18.423 boysNS
Spencer et al, 19924Mph 31.429NSp = 0.023 (1.2 years)1.5 at 1.2 years p = 0.035
Lisska and Rivkees, 20035Mph 21.684Boys p = 0.01 (3 and 4 years) Girls p = 0.05 (3 years)Boys 3–4 at 3 years Girls 3–4 at 3 years
MTA Cooperative Group 2001,6 20047Mph 34.42221.05 at 14 months p<0.001 1.92 at 24 months p<0.001
Design: longitudinal from onset of treatment with stimulant
Control: normative data
Treatment (mg/day)nΔ Height centileΔ Height z-scoreHeight deficit (cm)
Gross 19768Mph 34, Dex 16.584NS
Millichap, 19789Mph 10–2036 boysNS
Satterfield et al, 197910Mph 24.272 boys1.03 at 1 year p<0.001 0.1 at 2 years NS
Kaffman et al, 197911Mph 20, Dex 2050NS
Greenhill et al, 198112Dex 2113 boysp<0.025 (1 year)1.8 at 1 year p<0.005
Mattes and Gittelman, 198313Mph 41.356p<0.001 (2, 3, 4 years)3.3 at 4 years
Gadow et al, 199914Mph 30340.67 at 2 years NS
Poulton and Cowell, 200315Mph 27, Dex 13.751p<0.001 (½, 1½ years)0.64 at ½year p<0.001 2.33 at 2½years p<0.01
Design: longitudinal from onset of treatment with stimulant
Control: partially treated children
Treatment (mg/day)nΔ Height centile
Quinn and Rapoport 197516Mph 20.623 boysNS
Design: longitudinal from onset of treatment with stimulant
Control: none
Treatment (mg/day)nHeight velocity
Sund and Zeiner 200217Mph 23.9 Dex 11.991 boysNS
Design: longitudinal study of children changing formulation
Control: none
Duration of treatment prior to studyTreatment (mg/day)nChange in average height of cohort
Wilens et al, 200318Not stated (most were treated)Mph 18–54407 at start 229 at 1 yearNS
Design: cross sectional
Control: untreated children with ADHD or normal children
Duration of treatment prior to studyTreatment (mg/day)nHeight z-scoreHeight velocity
McNutt et al, 1976,19 1977209–47 months mean 30.3Mph 19.820NS
Spencer et al, 1996,21 199822Average 4 years follow upAny treatment ever110 boysp = 0.03
Mph 38†53 boysNS
Biederman et al, 200323Not statedAny treatment ever87 girlsNS
Mph 28†73 girlsNS
Design: cross sectional
Control: normative data
Duration of treatment prior to studyTreatment (mg/day)nHeight centileHeight velocity
n, number of subjects; Mph, methylphenidate daily dose; Dex, dexamphetamine/amphetamine daily dose; NS, method used but did not show statistically significant evidence of attenuated growth.
*The height deficits in Safer and Allen’s studies represent averaged annual deficits from children in their first, second, or third year of treatment.
†Average dose of methylphenidate or equivalent in subgroup of children who received a stimulant in past 2 years.
Millichap and Millichap, 1975241–5 years mean 2½ yearsMph 10–4050NS
Vincent et al, 199025½–7 yearsMph 3431NS